UNITÉ DE FABRICATION DES MÉDICAMENTS S.A |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.2 TND | -0.69% |
|
+0.56% | -3.74% |
Business Summary
- generic medicines: primarily infusion and inhalation products, ophthalmic products, injectable liquids and powders;
- fashioned medicines: medicines manufactured for third parties.
Number of employees: 572
Sales per Business
| TND in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 85 | 100.0 % | 96 | 100.0 % | +14.03% |
Sales per region
| TND in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
Tunisia
100.0
%
| 85 | 100.0 % | 96 | 100.0 % | +14.03% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 88-12-31 | |
| Director of Finance/CFO | - | - | |
Imen Charfeddine
CTO | Chief Tech/Sci/R&D Officer | - | - |
Imen Bemri
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rached Azaiez
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Comptroller/Controller/Auditor | - | 22-12-31 | |
Hafedh Elabed
AUD | Comptroller/Controller/Auditor | - | - |
| Corporate Officer/Principal | - | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 88-12-31 | |
| Director of Finance/CFO | - | - | |
Salah Ben Turkia
BRD | Director/Board Member | - | 15-12-31 |
Hichem ben Hmida
BRD | Director/Board Member | - | 21-12-31 |
Imen Bou Hamid
BRD | Director/Board Member | - | 22-12-31 |
Mondher Achour
BRD | Director/Board Member | - | 22-12-31 |
Salim Ouali
BRD | Director/Board Member | - | 22-12-31 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 32,000,000 | 9,594,370 ( 29.98 %) | 0 | 29.98 % |
Company contact information
Unité de Fabrication de Médicaments
Industrial Zone Kalaa Kebira
4060, Sousse
+
http://www.unimed.com.tn
Sector
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.2
TND
Average target price
11.9
TND
Spread / Average Target
+65.28%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.74% | 73.24M | |
| +33.25% | 704B | |
| +28.59% | 577B | |
| -3.55% | 348B | |
| +18.16% | 327B | |
| +4.36% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -3.69% | 147B |
- Stock Market
- Equities
- UMED Stock
- Company Unité de Fabrication des Médicaments S.A
